A different way to look at this is at the maximum tolerated dose for Carfilzomib in mice adding bisantrene on top doesn't kill the mice (i.e. the combination works well together in regards toxicity).
- Forums
- ASX - By Stock
- RAC
- Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-39
-
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.055(3.61%) |
Mkt cap ! $250.5M |
Open | High | Low | Value | Volume |
$1.53 | $1.58 | $1.46 | $143.9K | 96.36K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 230 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 550 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 230 | 1.465 |
1 | 410 | 1.460 |
3 | 46800 | 1.450 |
2 | 25548 | 1.440 |
1 | 2046 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 550 | 1 |
1.490 | 2470 | 1 |
1.535 | 2456 | 2 |
1.570 | 37690 | 1 |
1.575 | 2000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online